NCT03865888View on ClinicalTrials.gov

Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 30, 2018

Primary Completion Date

February 1, 2019

Study Completion Date

April 30, 2019

Conditions
Dry EyeSjogren Syndrome
Interventions
DRUG

Cyclosporins

Cyclosporins eye drops to be administered in dry eyes

DRUG

Tacrolimus

Tacrolimus eye drops to be administered in dry eyes

Trial Locations (1)

11421

Pavly Moawad, Cairo

All Listed Sponsors
lead

Pavly Moawd

OTHER

NCT03865888 - Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome | Biotech Hunter | Biotech Hunter